Paper1375111
Mutations of p53 gene and their relation to disease progression in B-cell lymphoma.
Ichikawa A and 8 others. Blood, 1992. Cited by 167 papers, by iCite.
Cite this record
ConductScience Library. Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Papers, record 1375111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1375111
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genes, p53 | Major topic |
| Lymphoma, B-Cell | Major topic |
| Mutation | Major topic |
| Base Sequence | |
| DNA, Neoplasm | |
| Exons | |
| Female | |
| Humans | |
| Lymph Nodes | |
| Male | |
| Middle Aged | |
| Molecular Sequence Data | |
| Nucleic Acid Conformation | |
| Oligodeoxyribonucleotides | |
| Polymerase Chain Reaction | |
| Polymorphism, Genetic | |
| Prognosis | |
| RNA, Neoplasm | |
| RNA-Directed DNA Polymerase |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 167 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38533514 | Single-cell transcriptome sequencing provides insight into multiple chemotherapy resistance in a patient with refractory DLBCL: a case report. | Front Immunol | 2024 | https://conductscience.org/library/papers/38533514 | PubMed |
| 36531038 | Advances in highly active one-carbon metabolism in cancer diagnosis, treatment and drug resistance: A systematic review. | Front Oncol | 2022 | https://conductscience.org/library/papers/36531038 | PubMed |
| 34804942 | Development and Validation of a Novel Prognostic Nomogram for CD5-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Study in China. | Front Oncol | 2021 | https://conductscience.org/library/papers/34804942 | PubMed |
| 33204162 | Characteristics and Management of TP53-Mutated Diffuse Large B-Cell Lymphoma Patients. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33204162 | PubMed |
| 26678182 | Mutation of p53 Gene and Its Correlation with the Clinical Outcome in Dogs with Lymphoma. | J Vet Intern Med | 2016 | https://conductscience.org/library/papers/26678182 | PubMed |
| 20425379 | Richter's transformation in chronic lymphocytic leukemia. | Curr Hematol Malig Rep | 2007 | https://conductscience.org/library/papers/20425379 | PubMed |
| 17609875 | Mutation of the p53 tumour suppressor gene and overexpression of its protein in 62 Japanese non-Hodgkin's lymphomas. | Clin Exp Med | 2007 | https://conductscience.org/library/papers/17609875 | PubMed |
| 17050200 | Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma. | Int J Hematol | 2006 | https://conductscience.org/library/papers/17050200 | PubMed |
| 15902285 | A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. | Leukemia | 2005 | https://conductscience.org/library/papers/15902285 | PubMed |
| 12840870 | P53 gene mutations in non-Hodgkin's lymphoma. | J Tongji Med Univ | 1999 | https://conductscience.org/library/papers/12840870 | PubMed |
| 12592341 | Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia. | Leukemia | 2003 | https://conductscience.org/library/papers/12592341 | PubMed |
| 12040438 | Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL). | Leukemia | 2002 | https://conductscience.org/library/papers/12040438 | PubMed |
| 12032783 | Tumor suppressor genes in normal and malignant hematopoiesis. | Oncogene | 2002 | https://conductscience.org/library/papers/12032783 | PubMed |
| 11927008 | Mutations of p53, c-kit, K-ras, and beta-catenin gene in non-Hodgkin's lymphoma of adrenal gland. | Jpn J Cancer Res | 2002 | https://conductscience.org/library/papers/11927008 | PubMed |
| 11804283 | Homozygous deletion of INK4a/ARF genes and overexpression of bcl-2 in relation with poor prognosis in immunocompetent patients with primary central nervous system lymphoma of the diffuse large B-cell type. | J Neurooncol | 2001 | https://conductscience.org/library/papers/11804283 | PubMed |
| 9546285 | Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL. | Brain Pathol | 1998 | https://conductscience.org/library/papers/9546285 | PubMed |
| 9057657 | Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells. | Blood | 1997 | https://conductscience.org/library/papers/9057657 | PubMed |
| 8669486 | Molecular characterization of primary mediastinal B cell lymphoma. | Am J Pathol | 1996 | https://conductscience.org/library/papers/8669486 | PubMed |
| 8398688 | Tumourigenesis associated with the p53 tumour suppressor gene. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8398688 | PubMed |
| 8297731 | p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time. | Br J Cancer | 1994 | https://conductscience.org/library/papers/8297731 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1375111
GET https://conductscience.org/api/papers/v1/1375111/cited_by?page=2